206 related articles for article (PubMed ID: 26457892)
1. Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G.
Fokkink WJ; Falck D; Santbergen TC; Huizinga R; Wuhrer M; Jacobs BC
PLoS One; 2015; 10(10):e0139828. PubMed ID: 26457892
[TBL] [Abstract][Full Text] [Related]
2. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
3. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
4. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
5. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494
[TBL] [Abstract][Full Text] [Related]
6. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV
Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.
Kapur R; Della Valle L; Verhagen OJ; Hipgrave Ederveen A; Ligthart P; de Haas M; Kumpel B; Wuhrer M; van der Schoot CE; Vidarsson G
Transfusion; 2015 Mar; 55(3):553-62. PubMed ID: 25234110
[TBL] [Abstract][Full Text] [Related]
8. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
de Haan N; Reiding KR; Driessen G; van der Burg M; Wuhrer M
J Proteome Res; 2016 Jun; 15(6):1853-61. PubMed ID: 27161864
[TBL] [Abstract][Full Text] [Related]
9. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
[TBL] [Abstract][Full Text] [Related]
10. Traces of pFc' in IVIG interact with human IgG Fc domains and counteract aggregation.
Rispens T; Himly M; Ooievaar-De Heer P; den Bleker TH; Aalberse RC
Eur J Pharm Sci; 2010 Apr; 40(1):62-8. PubMed ID: 20211252
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
Kaneko Y; Nimmerjahn F; Ravetch JV
Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.
Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ
J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289
[TBL] [Abstract][Full Text] [Related]
14. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
16. 7th International Immunoglobulin Conference: Mechanisms of action.
Basta M; Branch DR
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G.
Einarsdottir HK; Selman MH; Kapur R; Scherjon S; Koeleman CA; Deelder AM; van der Schoot CE; Vidarsson G; Wuhrer M
Glycoconj J; 2013 Feb; 30(2):147-57. PubMed ID: 22572841
[TBL] [Abstract][Full Text] [Related]
18. Analytical characterization of IgG Fc subclass variants through high-resolution separation combined with multiple LC-MS identification.
He XA; Washburn N; Arevalo E; Robblee JH
Anal Bioanal Chem; 2015 Sep; 407(23):7055-66. PubMed ID: 26231686
[TBL] [Abstract][Full Text] [Related]
19. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.
Baković MP; Selman MH; Hoffmann M; Rudan I; Campbell H; Deelder AM; Lauc G; Wuhrer M
J Proteome Res; 2013 Feb; 12(2):821-31. PubMed ID: 23298168
[TBL] [Abstract][Full Text] [Related]
20. Glycation of polyclonal IgGs: Effect of sugar excipients during stability studies.
Leblanc Y; Bihoreau N; Jube M; Andre MH; Tellier Z; Chevreux G
Eur J Pharm Biopharm; 2016 May; 102():185-90. PubMed ID: 26992291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
